Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (”Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today provided an update on its two patent ...

In Restem, LLC v. Jadi Cell, LLC, No. 2023-2054 (Fed. Cir. Mar. 13, 2025), the Federal Circuit upheld the Patent Trial and Appeal Board’s ...

European patent-licensing company Sisvel filed a flurry of lawsuits against a dozen tech companies who had allegedly ...

A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...

An analysis of Software as a Service (SaaS) patenting in the US Patent and Trademark Office, including the challenges in ...

Yesterday, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision in Restem, LLC v. Jadi Cell LLC ...

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

Holdings rovided an update on its two patent applications, originally filed as provisional patent applications with the ...

Whether you’re NASA Administrator nominee Jared Isaacman, Virgin Galactic Founder Richard Branson, Artemis mission specialist ...

A new leak suggests that a new prototype for Apple's rumored foldable iPad or MacBook device could have Face ID tech beneath ...

Rutgers has been a fixture in the NAI Top 100 Worldwide Universities List, appearing in all 12 rankings since its inception ...